Filing Flows › CVS Health (CVS) › Q2 2026 › vs Q2 2025
CVS Health (CVS) Q2 2026 vs Q2 2025 (year over year)
CVS Health's revenue rose $7.2B (+7%) from $98.9B in Q2 2025 to $106.1B in Q2 2026. Operating margin 4.4% against 2.4% (+2.0 pts).
CVS Health, Q2 2026: revenue $106.1B (+7% year over year), operating margin 4.4%, net earnings $3.0B, operating cash flow $6.3B. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Operating margin | 4.4% | 2.4% | +2.0 pts |
| Net margin | 2.8% | 1.0% | +1.8 pts |
| Free cash flow margin | 5.3% | 1.3% | +4.0 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $106.1B | $98.9B | $7.2B | +7% |
| Operating profit | $4.7B | $2.4B | $2.3B | +98% |
| Costs & expenses | $101.4B | $96.5B | $4.9B | +5% |
| Pre-tax earnings | $4.0B | $1.6B | $2.3B | +141% |
| Other expense, net | $726M | $734M | −$8.0M | -1% |
| Cost of revenue | $58.9B | $54.0B | $4.9B | +9% |
| Other operating costs | $42.5B | $42.5B | $2.0M | 0% |
| Net earnings | $3.0B | $1.0B | $2.0B | +196% |
| Income tax | $982M | $634M | $348M | +55% |
| Depreciation & amortization | $1.1B | $1.2B | −$45.0M | -4% |
| Share-based compensation | $176M | $136M | $40.0M | +29% |
| Working capital & other | $2.0B | −$423M | $2.5B | — |
| Operating cash flow | $6.3B | $1.9B | $4.4B | +234% |
| Free cash flow (OCF − capex) | $5.7B | $1.3B | $4.4B | +338% |
| Capital expenditures | $691M | $607M | $84.0M | +14% |
Questions
How much did CVS Health's revenue grow year over year in Q2 2026?
CVS Health's revenue rose $7.2B (+7%) from $98.9B in Q2 2025 to $106.1B in Q2 2026. Operating margin 4.4% against 2.4% (+2.0 pts).